Sodium butyrate induces cellular senescence in neuroblastoma and prostate cancer cells

Insights

Histone deacetylase (HDAC) inhibitors like sodium butyrate (NaBu) induce cellular senescence, a cell division arrest, in cancer cells. This epigenetic regulation, linked to reactive oxygen species (ROS), offers a promising avenue for tumor suppression.

Area of Science:

  • Epigenetics
  • Cancer Biology
  • Cellular Senescence

Background:

  • Cellular senescence irreversibly blocks cell division, a valuable mechanism for cancer treatment.
  • Histone deacetylases (HDACs) are key therapeutic targets in oncology, with HDAC inhibitors showing promise in clinical trials.
  • Understanding novel inducers of senescence is crucial for developing new anti-cancer strategies.

Purpose of the Study:

  • To investigate whether sodium butyrate (NaBu), a class I and II HDAC inhibitor, induces cellular senescence in neuroblastoma and prostate cancer (PCa) cell lines.
  • To explore the effects of other HDAC inhibitors, including a SIRT1 inhibitor, on tumor cell senescence.
  • To elucidate the molecular mechanisms underlying HDAC inhibitor-induced senescence, focusing on gene expression and reactive oxygen species (ROS) production.

Main Methods:

  • Treatment of neuroblastoma and human prostate cancer cell lines (androgen-dependent and independent) with HDAC inhibitors (NaBu, valproic acid (VPA), and a SIRT1 inhibitor).
  • Assessment of cellular senescence markers, including Senescence-Associated β-galactosidase (SA-β-Gal) and Senescence-Associated Heterochromatin Foci (SAHF).
  • Analysis of mRNA levels for proto-oncogenes (c-Myc, Cyclin D1, E2F1), cell cycle inhibitors (p16), and tumor suppressors (p21).
  • Measurement of reactive oxygen species (ROS) levels following NaBu treatment.

Main Results:

  • Both NaBu and VPA, HDAC inhibitors, effectively induced cellular senescence in tested tumor cell lines.
  • A SIRT1 inhibitor also triggered cellular senescence, indicating a role for class III HDACs.
  • Senescence markers (SA-β-Gal, SAHF) were expressed in neuroblastoma and prostate cancer cells.
  • NaBu downregulated c-Myc, Cyclin D1, and E2F1 mRNA, while upregulating p21 and leaving p16 unchanged.
  • NaBu treatment significantly increased ROS levels in tumor cells.

Conclusions:

  • HDAC inhibitors, including NaBu, are potent inducers of cellular senescence in various cancer types.
  • The induction of senescence by HDAC inhibitors involves epigenetic modifications and is associated with increased ROS production.
  • Targeting HDACs represents a viable strategy for cancer treatment by promoting tumor cell senescence and suppression.

Related Concept Videos

Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
4.4K
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
7.0K
Regulation of Sodium and Potassium01:26

Regulation of Sodium and Potassium

The regulation of sodium and potassium ion concentrations in the human body is a complex process governed primarily by hormones such as aldosterone, antidiuretic hormone (ADH), and atrial natriuretic peptide (ANP).
Sodium Regulation
Sodium ions make up approximately 90% of extracellular cations, with a normal blood plasma concentration of 136–148 mEq/L. A decrease in blood volume and pressure triggers the release of renin from granular cells in the juxtaglomerular complex (JGC), primarily...
2.3K
Roles of Electrolytes: Sodium and Potassium01:24

Roles of Electrolytes: Sodium and Potassium

Sodium plays a crucial role in maintaining fluid and electrolyte balance and overall bodily homeostasis. Sodium balance is primarily regulated by kidney function, which adjusts sodium elimination to match dietary intake and maintain proper electrolyte levels. Sodium is the most abundant cation in the extracellular fluid (ECF) and is found in salts such as sodium chloride (NaCl) and sodium bicarbonate (NaHCO3). Although cellular plasma membranes are relatively impermeable to sodium, its role in...
2.2K
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
28.1K
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
1.8K